Insider Trading activities of Advanced Cell Technology, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Advanced Cell Technology, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Advanced Cell Technology, Inc. since year 2005. Table 2 shows the detailed insider transactions of Advanced Cell Technology, Inc. since 2005. The reporting company's ticker symbol is OCAT. The reporting company's CIK number is 1140098.
The total value of stock buying since 2005 is $0.
The total value of stock sales since 2005 is $6,135,440.
The total value of stock option exercises since 2005 is $52,500.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Advanced Cell Technology, Inc. (OCAT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2015-11 0 $0 35,000 $291,305 0 $0
2014-09 0 $0 48,930 $480,936 0 $0
2014-07 0 $0 1,500,000 $120,000 0 $0
2013-01 0 $0 1,000,000 $79,000 0 $0
2012-12 0 $0 1,338,490 $78,970 0 $0
2012-10 0 $0 1,000,000 $70,349 0 $0
2012-09 0 $0 1,000,000 $81,999 0 $0
2012-08 0 $0 1,000,000 $78,000 0 $0
2012-07 0 $0 2,000,000 $161,500 0 $0
2012-06 0 $0 1,175,029 $84,824 0 $0
2012-05 0 $0 1,199,971 $90,209 0 $0
2012-01 0 $0 8,283,300 $1,562,768 0 $0
2011-10 0 $0 1,999,999 $287,636 0 $0
2011-09 0 $0 726,305 $111,006 0 $0
2011-08 0 $0 2,050,000 $339,835 0 $0
2011-06 0 $0 0 $0 750,000 $37,500
2011-05 0 $0 1,016,898 $202,795 0 $0
2011-04 0 $0 733,102 $129,759 0 $0
2011-03 0 $0 1,960,630 $319,848 0 $0
2011-02 0 $0 2,386,244 $434,085 0 $0
2010-12 0 $0 2,000,000 $278,736 0 $0
2010-11 0 $0 6,261,000 $576,272 0 $0
2010-09 0 $0 600,000 $40,800 0 $0
2010-08 0 $0 600,000 $45,000 0 $0
2010-07 0 $0 600,000 $42,496 0 $0
2010-06 0 $0 600,000 $58,200 0 $0
2010-05 0 $0 600,000 $39,600 0 $0
2010-04 0 $0 439,023 $39,512 0 $0
2007-12 0 $0 50,000 $10,000 0 $0
2007-10 0 $0 0 $0 300,000 $15,000

Table 2. Detailed insider stock purchases, sales, and option exercises of Advanced Cell Technology, Inc. insiders (OCAT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2015-11-10 Lanza Robert (Chief Scientific Officer) Sale 35,000 8.32 291,305
2014-09-10 Lanza Robert (Chief Scientific Officer) Sale 8,930 12.54 111,937
2014-09-08 Lanza Robert (Chief Scientific Officer) Sale 15,000 10.04 150,525
2014-09-03 Lanza Robert (Chief Scientific Officer) Sale 10,000 9.00 90,000
2014-09-02 Lanza Robert (Chief Scientific Officer) Sale 15,000 8.56 128,474
2014-07-07 Lanza Robert (Chief Scientific Officer) Sale 745,000 .08 59,600
2014-07-03 Lanza Robert (Chief Scientific Officer) Sale 755,000 .08 60,400
2013-01-10 Rabin Gary H (CEO & CFO) Sale 1,000,000 .08 79,000
2012-12-14 Lanza Robert (Chief Scientific Officer) Sale 1,338,490 .06 78,970
2012-10-23 Rabin Gary H (CEO & CFO) Sale 650,000 .07 45,500
2012-10-22 Rabin Gary H (CEO & CFO) Sale 350,000 .07 24,849
2012-09-06 Rabin Gary H (CEO & CFO) Sale 391,444 .08 32,098
2012-09-05 Rabin Gary H (CEO & CFO) Sale 608,556 .08 49,901
2012-08-27 Rabin Gary H (CEO & CFO) Sale 1,000,000 .08 78,000
2012-07-31 Lanza Robert (Chief Scientific Officer) Sale 500,000 .08 40,000
2012-07-30 Lanza Robert (Chief Scientific Officer) Sale 1,500,000 .08 121,500
2012-06-15 Rabin Gary H (CEO & CFO) Sale 350,000 .07 25,199
2012-06-14 Rabin Gary H (CEO & CFO) Sale 350,000 .07 25,199
2012-06-13 Rabin Gary H (CEO & CFO) Sale 300,000 .07 21,299
2012-06-11 Rabin Gary H (CEO & CFO) Sale 175,029 .08 13,127
2012-05-29 Rabin Gary H (CEO & CFO) Sale 24,500 .08 1,960
2012-05-25 Rabin Gary H (CEO & CFO) Sale 80,000 .08 6,480
2012-05-24 Rabin Gary H (CEO & CFO) Sale 95,471 .08 7,637
2012-05-14 Rabin Gary H (CEO & CFO) Sale 388,090 .07 26,778
2012-05-11 Rabin Gary H (CEO & CFO) Sale 290,000 .07 20,880
2012-05-07 Rabin Gary H (CEO & CFO) Sale 122,000 .08 9,882
2012-05-03 Rabin Gary H (CEO & CFO) Sale 199,910 .08 16,592
2012-01-24 Lanza Robert (Chief Scientific Officer) Sale 6,658,300 .19 1,278,393
2012-01-23 Rabin Gary H (CEO & CFO) Sale 625,000 .18 109,375
2012-01-23 Lanza Robert (Chief Scientific Officer) Sale 1,000,000 .18 175,000
2011-10-14 Rabin Gary H (CEO & CFO) Sale 720,920 .14 104,533
2011-10-13 Rabin Gary H (CEO & CFO) Sale 787,429 .14 111,814
2011-10-12 Rabin Gary H (CEO & CFO) Sale 491,650 .14 71,289
2011-09-29 Lanza Robert (Chief Scientific Officer) Sale 608,225 .15 93,058
2011-09-28 Lanza Robert (Chief Scientific Officer) Sale 118,080 .15 17,948
2011-08-12 Rabin Gary H (CEO & CFO) Sale 539,987 .17 91,797
2011-08-11 Rabin Gary H (CEO & CFO) Sale 707,913 .16 116,097
2011-08-10 Rabin Gary H (CEO & CFO) Sale 135,100 .16 21,886
2011-08-09 Rabin Gary H (CEO & CFO) Sale 667,000 .16 110,055
2011-06-21 Lanza Robert (Chief Scientific Officer) Option Ex 750,000 .05 37,500
2011-05-20 Rabin Gary H (CEO & CFO) Sale 750,000 .20 150,750
2011-05-04 Rabin Gary H (CEO & CFO) Sale 266,898 .20 52,045
2011-04-26 Rabin Gary H (CEO & CFO) Sale 733,102 .18 129,759
2011-03-17 Rabin Gary H (CEO & CFO) Sale 4,000 .16 628
2011-03-15 Rabin Gary H (CEO & CFO) Sale 1,196,000 .16 191,360
2011-03-07 Ruoslahti Erkki (Director) Sale 250,000 .17 41,750
2011-03-04 Ruoslahti Erkki (Director) Sale 250,000 .17 41,750
2011-03-03 Ruoslahti Erkki (Director) Sale 250,000 .17 42,500
2011-03-01 Ruoslahti Erkki (Director) Sale 10,630 .18 1,860
2011-02-28 Rabin Gary H (CEO & CFO) Sale 390,993 .17 68,032
2011-02-28 Ruoslahti Erkki (Director) Sale 250,000 .18 43,750
2011-02-25 Ruoslahti Erkki (Director) Sale 72,050 .18 12,608
2011-02-18 Ruoslahti Erkki (Director) Sale 250,000 .18 43,750
2011-02-17 Ruoslahti Erkki (Director) Sale 135,551 .18 23,856
2011-02-14 Ruoslahti Erkki (Director) Sale 400,000 .19 74,400
2011-02-11 Ruoslahti Erkki (Director) Sale 137,650 .18 25,189
2011-02-10 Ruoslahti Erkki (Director) Sale 250,000 .19 46,500
2011-02-09 Rabin Gary H (CEO & CFO) Sale 250,000 .19 47,250
2011-02-07 Rabin Gary H (CEO & CFO) Sale 250,000 .20 48,750
2010-12-07 Lanza Robert (Chief Scientific Officer) Sale 728,136 .15 107,035
2010-12-06 Lanza Robert (Chief Scientific Officer) Sale 1,271,864 .14 171,701
2010-11-30 Lanza Robert (Chief Scientific Officer) Sale 3,800,000 .10 383,800
2010-11-29 Lanza Robert (Chief Scientific Officer) Sale 1,000,000 .08 83,000
2010-11-23 Lanza Robert (Chief Scientific Officer) Sale 679,000 .08 51,604
2010-11-22 Lanza Robert (Chief Scientific Officer) Sale 782,000 .07 57,868
2010-09-20 Lanza Robert (Chief Scientific Officer) Sale 600,000 .07 40,800
2010-08-20 Lanza Robert (Chief Scientfic Officer) Sale 600,000 .08 45,000
2010-07-21 Lanza Robert (Chief Scientific Officer) Sale 102,850 .07 7,199
2010-07-20 Lanza Robert (Chief Scientific Officer) Sale 497,150 .07 35,297
2010-06-21 Lanza Robert (Chief Scientific Officer) Sale 600,000 .10 58,200
2010-05-20 Lanza Robert (Chief Scientific Officer) Sale 600,000 .07 39,600
2010-04-20 Lanza Robert (Chief Scientific Officer) Sale 439,023 .09 39,512
2007-12-14 Atzen Jonathan F (SVP and General Counsel) Sale 50,000 .20 10,000
2007-10-09 West Michael D Option Ex 300,000 .05 15,000

Insider trading activities including stock purchases, stock sales, and option exercises of OCAT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Advanced Cell Technology, Inc. (symbol OCAT, CIK number 1140098) see the Securities and Exchange Commission (SEC) website.